Our constant goal is to optimize drug development, in order to produce complex generic and specialty drugs that are more accessible to patients.

We constantly strive to improve the technology used to develop quality products, aimed at timely delivery. Therefore, we consider it most beneficial to have R&D activities of both API and formulations under one roof. As a result, our infrastructure now includes 4 fully-equipped formulation and analytical method development labs, with an integrated R&D facility.

We have accomplished complex drug development that is economically feasible. We have done so by using world-class, eco-sustainable infrastructure and cutting-edge technology for the manufacturing of our finished dosages and formulations.

MSN laboratories manufactures an extensive range of finished dosages and formulations (FDFs) including tablets, capsules, ampoules, vials & lyophilized vials. Our manufacturing capabilities include:

Drug manufacturing:

Capability of manufacturing sites:

Work in progress:

The MSN Group’s DMFs filing has significantly increased over the years and our major accomplishments have been:

With record filing of DMFs and certificates of suitability (CEPs), our 300+ customers have first-hand experience of our operational excellence and dedication to pharmaceutical modernization.